Fjord Ventures: Adagio Medical Raises $42.5M In Series E Funding

Adagio Medical, Inc., a Laguna Hills, Calif.-based provider of treatments for atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the Continuous Lesion Ablation System (iCLAS ), closed a $42.5m Series E equity financing. Backers included new investors ArrowMark Partners, RA Capital Management and Perceptive Advisors, who joined existing investors including JMR Capital and Fjord Ventures. Tuan Huynh of ArrowMark [...] The post Adagio Medical Raises $42.5M In Series E Funding appeared first on FinSMEs.